These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17908587)

  • 21. The current status of the Papanicolaou smear.
    Shingleton HM; Patrick RL; Johnston WW; Smith RA
    CA Cancer J Clin; 1995; 45(5):305-20. PubMed ID: 7656133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homogeneous sampling accounts for the increased diagnostic accuracy using the ThinPrep Processor.
    Hutchinson ML; Isenstein LM; Goodman A; Hurley AA; Douglass KL; Mui KK; Patten FW; Zahniser DJ
    Am J Clin Pathol; 1994 Feb; 101(2):215-9. PubMed ID: 8116578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is it now time to evaluate the true accuracy of cervical cytology screening? A review of the literature.
    Martin-Hirsch PL; Koliopoulos G; Paraskevaidis E
    Eur J Gynaecol Oncol; 2002; 23(4):363-5. PubMed ID: 12214747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the Papanicolaou smear in diagnosis of chlamydial infections.
    Arroyo G; Linnemann C; Wesseler T
    Sex Transm Dis; 1989; 16(1):11-4. PubMed ID: 2667150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical squamous cells of undetermined significance: a comparative review of original and automated rescreen diagnosis of cervicovaginal smears with long term follow-up.
    Stastny JF; Remmers RE; London WB; Pedigo MA; Cahill LA; Ryan M; Frable WJ
    Cancer; 1997 Dec; 81(6):348-53. PubMed ID: 9438460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does gel affect cytology or comfort in the screening papanicolaou smear?
    Gilson M; Desai A; Cardoza-Favarato G; Vroman P; Thornton JA
    J Am Board Fam Med; 2006; 19(4):340-4. PubMed ID: 16809647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The false-negative fraction: a statistical method to measure the efficacy of cervical smear screening laboratories.
    Dolinar J; Ollayos CW; Tellado M; Ali I; Stevens A; Paquette C; Brodbelt S
    Mil Med; 1999 Jun; 164(6):410-1. PubMed ID: 10377709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Winning the Pap smear case.
    Campbell JB
    Diagn Cytopathol; 1999 Oct; 21(4):238-9. PubMed ID: 10495315
    [No Abstract]   [Full Text] [Related]  

  • 29. Utility of cervicography in HIV-infected and uninfected adolescents.
    Moscicki AB; Durako SJ; Ma Y; Darragh T; Vermund SH
    J Adolesc Health; 2003 Mar; 32(3):204-13. PubMed ID: 12606114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effectiveness of photodynamic diagnosis method in diagnosis of cervical lesions].
    Nowakowski Z; Kietlińska Z; Stelmachów J
    Ginekol Pol; 2002 Nov; 73(11):930-3. PubMed ID: 12722376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
    Budge M; Halford J; Haran M; Mein J; Wright G
    Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are fluid-based cytologies superior to the conventional Papanicolaou test? A systematic review.
    Sulik SM; Kroeger K; Schultz JK; Brown JL; Becker LA; Grant WD
    J Fam Pract; 2001 Dec; 50(12):1040-6. PubMed ID: 11742605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The determination of Papanicolaou smear adequacy using a semiquantitative method to evaluate cellularity.
    Valente PT; Schantz HD; Trabal JF
    Diagn Cytopathol; 1991; 7(6):576-80. PubMed ID: 1769285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis.
    Wiese W; Patel SR; Patel SC; Ohl CA; Estrada CA
    Am J Med; 2000 Mar; 108(4):301-8. PubMed ID: 11014723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ThinPrep Pap Test. Accuracy for glandular disease.
    Ashfaq R; Gibbons D; Vela C; Saboorian MH; Iliya F
    Acta Cytol; 1999; 43(1):81-5. PubMed ID: 9987455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix. A study of 34 cases.
    Lee KR; Minter LJ; Granter SR
    Am J Clin Pathol; 1997 Jan; 107(1):30-5. PubMed ID: 8980364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of Cervical Pap Smear with Biopsy in the Lesion of Cervix.
    Dhakal R; Makaju R; Sharma S; Bhandari S; Shrestha S; Bastakoti R
    Kathmandu Univ Med J (KUMJ); 2016 Jul-Sept.; 14(55):254-257. PubMed ID: 28814689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating the percentage of Papanicolaou smears that can be reproducibly identified: modeling Papanicolaou smear interpretation based on multiple blinded rescreenings.
    Renshaw AA
    Cancer; 2001 Aug; 93(4):241-5. PubMed ID: 11507696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Bethesda system and evaluation of abnormal pap smears.
    Nguyen HN; Nordqvist SR
    Semin Surg Oncol; 1999; 16(3):217-21. PubMed ID: 10225298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of monolayered cervical smears in a gynecology outpatient setting in Kuwait.
    Luthra UK; Chishti M; Dey P; Jolly SV; Abdulla M; Das DK; Sugathan TN; Ajrawi MT; George J; George SS; Aziz AA; al-Juwaiser A; Karim FA; Mallik MK; Sheikh ZA; Khan S
    Acta Cytol; 2002; 46(2):303-10. PubMed ID: 11917577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.